Biotech industry will continue to consolidate, sector analyst says

6:28 AM ET Fri, 4 Jan 2019

Alex Arfaei, pharmaceutical analyst from BMO Capital Markets Corp, joins "Squawk Box" with his analysis on where the biotech sector is headed following the Bristol-Myers Squibb's acquisition of Celgene.